Gene · 406941
Papers2,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-149 Promotes Apoptosis of Ovarian Granulosa Cells Through Inducing Caspase 8 Expression. | Animals (Basel) | 2026 | 42738452 | PubTator, text mining | PubMed |
| Systemic and local dysregulation of the complement system in glioma: a comprehensive systematic review. | Clin Transl Oncol | 2026 | 42627589 | PubTator, text mining | PubMed |
Retraction notice to "Vp1 protein peptide molecule and LAAO in liver cancer gene therapy: VN-NsLAAO fusion protein regulates mir-149-RAS liver cancer cell proliferation pathway" [Int. J. Biol. Macromol. 317 (2025) 144819]. | Int J Biol Macromol | 2026 | 42586841 | PubTator, text mining | PubMed |
| Neuroinflammation- molecular target based therapeutic approach. | Adv Protein Chem Struct Biol | 2026 | 42448410 | PubTator, text mining | PubMed |
| Genetic or pharmacological inhibition of hepatic TMEM141 attenuates MASH and fibrosis via the ROS-HNF4α signaling pathway. | Nat Commun | 2026 | 42443224 | PubTator, text mining | PubMed |
| Sonobiopsy for enrichment of circulating microRNAs in glioma patients. | Neurooncol Adv | 2026 | 42311796 | PubTator, text mining | PubMed |
| Regulation of exosomal miR-513a and miR-149 expression by APE1 in PD-L1 and TCR immune regulation pathways to promote immune evasion in osteosarcoma. | Cancer Genet | 2026 | 42217848 | PubTator, text mining | PubMed |
| Correction: Association of mir-196a-2 rs11614913 and mir-149 rs2292832 polymorphisms with risk of cancer: an updated meta-analysis. | Front Genet | 2026 | 41960147 | PubTator, text mining | PubMed |
| Overexpression of miR-149 attenuates opioid-related perturbations in neural stem cell fates and serves as a translational biomarker for infants with prenatal opioid exposure. | PLoS One | 2026 | 41915663 | PubTator, text mining | PubMed |
| Short and Long Non-Coding RNAs in Renal Cell Carcinoma. | Noncoding RNA | 2026 | 41874142 | PubTator, text mining | PubMed |
| Temporal trajectory of plasma miRNA during the peri-implantation stage: comparing implantation success and failure in single frozen-thawed blastocyst transfers. | Front Endocrinol (Lausanne) | 2026 | 41778162 | PubTator, text mining | PubMed |
| Environmental endocrine disruptors and endometrial cancer: a systematic review of epidemiological studies. | Front Endocrinol (Lausanne) | 2026 | 41767382 | PubTator, text mining | PubMed |
| A ESRP1/circPHGDH/miR-149/RAP1B positive feedback loop promotes the malignant behaviors and glycolysis of prostate cancer cell. | Exp Mol Med | 2026 | 41760734 | PubTator, text mining | PubMed |
| Plant-Derived Bioactive Compounds in Inflammation-Related Cancers: Mechanisms and Therapeutic Potential. | Plants (Basel) | 2026 | 41754282 | PubTator, text mining | PubMed |
| Precision Oncology in Ocular Melanoma: Integrating Molecular and Liquid Biopsy Biomarkers. | Curr Issues Mol Biol | 2026 | 41751395 | PubTator, text mining | PubMed |
| Tyrosine-Peptide Analog Modulates Extracellular Vesicles miRNAs Cargo from Mesenchymal Stem/Stromal and Cancer Cells to Drive Immunoregeneration and Tumor Suppression. | Biomolecules | 2026 | 41750312 | PubTator, text mining | PubMed |
| The dual role of autophagy in cartilage degradation: from mechanisms to targeted therapeutics. | Front Cell Dev Biol | 2026 | 41716288 | PubTator, text mining | PubMed |
| The Expression and Potential Role of MicroRNAs in Oral Lichen Planus. | J Oral Pathol Med | 2026 | 41635022 | PubTator, text mining | PubMed |
| Exercise-derived extracellular vesicles in oncology: a new frontier for translational nanomedicine. | J Transl Med | 2026 | 41606592 | PubTator, text mining | PubMed |
| Cellular iron flux measurement by micromagnetic resonance relaxometry as a critical quality attribute of mesenchymal stromal cells. | Stem Cells Transl Med | 2026 | 41582650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406941/papers